TAFINLAR is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test. (1.1, 2.1) TAFINLAR is indicated, in combination…
Principal Display Panel. NDC 0173-0846-08. Tafinlar® (Dabrafenib) Capsules 50 mg Rx only. 120 Capsules Federal Law requires dispensing of TAFINLAR® with the Medication Guide provided with this bottle. Each capsule contains 59.25 mg dabrafenib…
TAFINLAR is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved…
Dacarbazine is indicated in the treatment of metastatic malignant melanoma. In addition, dacarbazine is also indicated for Hodgkin’s disease as a second-line therapy when used in combination with other effective agents. CONTRAINDICATIONS:…
Dacarbazine for Injection is indicated in the treatment of metastatic malignant melanoma. In addition. Dacarbazine for Injection is also indicated for Hodgkin’s disease as a second-line therapy when used in combination with other effective agents…
As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2020. All Rights Reserved.